Managing Asthma During Pregnancy: Medications and Triggers
This paper examines the management of asthma during pregnancy, focusing on a patient presenting with a PEAK flow rate of 60%—placing her in the cautionary "yellow zone." The paper outlines the clinical risks of uncontrolled asthma during pregnancy, including high blood pressure, premature birth, and restricted fetal growth. It recommends a two-medication approach combining inhaled corticosteroids (budesonide) for long-term control and short-acting beta-agonists (albuterol) for acute symptom relief. The paper also emphasizes lifestyle interventions such as trigger avoidance, home environment management, and flu vaccination to reduce the risk of asthmatic attacks throughout the pregnancy.
- Overview of Asthma and PEAK Flow Assessment: Defines asthma and evaluates patient PEAK flow
- Risks of Uncontrolled Asthma During Pregnancy: Outlines complications from poorly controlled asthma
- Recommended Medications for Asthma Control: Proposes dual-medication regimen for patient
- Trigger Avoidance and Preventive Strategies: Advises lifestyle measures to reduce attack risk
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds clinical recommendations in patient-specific data (60% PEAK flow rate) rather than speaking in generalities, which strengthens the practical relevance of every recommendation.
- Clearly distinguishes between long-term control medications and short-acting rescue medications, demonstrating an understanding of the two-pronged pharmacological approach to asthma management.
- Integrates both pharmacological and non-pharmacological interventions, giving the management plan a holistic, clinically realistic character.
Key academic technique demonstrated
The paper effectively uses authoritative sources—the American Lung Association and a peer-reviewed journal article—to justify each clinical recommendation. By anchoring the PEAK flow interpretation to published guidelines and citing Murphy (2015) for pregnancy-specific goals, the writer demonstrates the technique of evidence-based reasoning: connecting observed patient data to established clinical standards before proposing treatment.
Structure breakdown
The paper follows a logical clinical progression: it opens with a general definition of asthma and a patient-specific assessment, moves to the risks posed by poor control during pregnancy, then details the recommended dual-medication regimen, and closes with trigger-avoidance and preventive lifestyle advice. Each paragraph builds on the previous one, moving from diagnosis to risk to treatment to prevention.
Overview of Asthma and PEAK Flow Assessment
Asthma is, in basic terms, a condition characterized by the narrowing and swelling of airways, as well as the production of extra mucus. This results in challenges in breathing, effectively triggering shortness of breath, wheezing, and coughing. It is important to note that there is no cure for asthma, and the control of asthmatic symptoms is therefore of the essence. According to the American Lung Association (2020), a person who has a PEAK flow rate of 80%–100% has reasonably good control of their asthma. On the other hand, as the American Lung Association further points out, "50 to 80 percent of your usual or 'normal' peak flow rate signals caution." The patient's PEAK flow performance is 60%. It should be noted that during pregnancy, uncontrolled asthma could present serious health challenges and risks for both the mother and the unborn baby. The relevance of using the appropriate medications and avoiding triggers is therefore paramount.
Risks of Uncontrolled Asthma During Pregnancy
In the present scenario, the overall goal ought to be the effective treatment of the patient's asthma and ensuring that it is well controlled during her pregnancy. When it comes to the management of asthma during pregnancy, Murphy (2015) observes that key "goals include the prevention of chronic day and night symptoms, maintenance of optimal pulmonary function and normal activities, and prevention of exacerbations, using therapies with minimal or no adverse side-effects" (Murphy, 2015, p. 260). Failure to effectively control asthma during pregnancy predisposes the mother to complications including, but not limited to, high blood pressure. Other serious complications that could result include premature birth, restricted fetal growth, and in extreme cases, stillbirth. With a PEAK flow performance of 60%, the patient is in what the American Lung Association refers to as the yellow zone. This signals caution and is indicative of narrowing airways. Intervention measures should therefore be taken to return her PEAK flow to the green zone.
References
American Lung Association. (2020). Measuring your peak flow rate. Retrieved from https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/living-with-asthma/managing-asthma/measuring-your-peak-flow-rate
Murphy, V. E. (2015). Managing asthma in pregnancy. Breathe (Sheff), 11(4), 258–267.
Create your account
Always verify citation format against your institution’s current style guide requirements.